Net profit of Fischer Medical Ventures rose 264.29% to Rs 0.51 crore in the quarter ended September 2024 as against Rs 0.14 crore during the previous quarter ended September 2023. There were no Sales reported in the quarter ended September 2024 as against Rs 0.19 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales00.19 -100 OPM %073.68 - PBDT0.460.15 207 PBT0.460.15 207 NP0.510.14 264 Powered by Capital Market - Live News

The Board of Fischer Medical Ventures at its meeting held on 13 November 2024 has approved the appointment of Vivek Balasubramanian as the Chief Financial Officer of the Company with effect from 13 November 2024. The Board accepted the resignation of Dilip Suryakant Jha who resigned as Chief Financial Officer of the Company with effect from 12 November 2024. Powered by Capital Market - Live News

Fischer Medical Ventures will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live News

Fischer Medical Ventures announced that the 31th Annual General Meeting (AGM) of the company will be held on 17 September 2024.Powered by Capital Market - Live News

Net profit of Fischer Medical Ventures reported to Rs 0.84 crore in the quarter ended June 2024 as against net loss of Rs 0.22 crore during the previous quarter ended June 2023. There were no Sales reported in the quarter ended June 2024 and during the previous quarter ended June 2023.Powered by Capital Market - Live News